Center for Scientific Review; Notice of Closed Meetings, 65676-65677 [2014-26209]
Download as PDF
<![CDATA[
65676
Federal Register / Vol. 79, No. 214 / Wednesday, November 5, 2014 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
management systems; (8) serves as the
IHS liaison with the HHS and the public
for grants and other financial assistance
programs within the IHS; (9) maintains
the Catalog of Federal Domestic
Assistance for IHS financial assistance
programs; (10) conducts grants-related
training for IHS staff, grantees, and
potential grantees; (11) coordinates
payment to grantees, including
scholarship recipients; and (12)
establishes and maintains the IHS
automated Grants Information System
and controls data entry into the HHS
automated Grants Information System.
Division of Regulatory Affairs (GALE)
(1) Manages the IHS’ overall
regulations program and
responsibilities, including determining
the need for and developing plans for
changes in regulations, developing or
assuring the development of needed
regulations, and maintaining the various
regulatory planning processes; (2) serves
as IHS liaison with the Office of the
Federal Register on matters relating to
the submission and clearance of
documents for publication in the
Federal Register; (3) assures proper
Agency clearance and processing of
Federal Register documents; (4) informs
management and program officials of
regulatory activities of other Federal
agencies; (5) manages the IHS review of
non-IHS regulatory documents that
impact the delivery of health services to
Indians including but not limited to
access and civil rights aspects and State
Medicaid waiver applications by
coordinating with the OGC Public
Health Division; (6) advises the IHS
Director and serves as liaison with the
OGC on such matters as litigation,
regulations, related policy issues, and
administrative support issues; (7)
determines the need for and obtains
legal clearance of IRS directives and
other issuances; (8) coordinates legal
issues with the OGC, IHS, HHS
components, and other Federal
agencies, including the identification
and formulation of legal questions and
advising on the implementation of OGC
opinions; (9) assures that IHS’ appeals
processes meet legal standards; (10)
advises on and participates in Indian
Self-Determination and Education
Assistance Act appeals and hearings;
(11) advises on the administration of the
contract health services (CHS) appeals
system and is a participant in the IRS
Director’s CHS appeal decisions; (12)
manages the retrieval and transmittal of
information in response to requests
received under the Freedom of
Information Act (FOIA), Privacy Act, the
Health Insurance Portability and
Accountability Act (HIPAA) Privacy and
VerDate Sep<11>2014
17:42 Nov 04, 2014
Jkt 235001
the Health Information Technology for
Economic and Clinical Health (HITECH)
Act, in collaboration with the Public
Affairs Staff; (13) ensures the security of
sensitive and/or confidential
information when responding to FOIA,
Privacy Act, HIPAA Privacy, and
HITECH Act issues; (14) advises the IHS
Director regarding requests for IHS
employees to serve as expert witnesses
when IRS is not a party to the suit; (15)
provides leadership and guidance for
the IHS Records Management Program;
(16) develops and recommends policies
and procedures for the protection and
disposition of JETS records and oversees
the evaluation of records management
activities in the IRS; (17) develops and
implements a management control
system for evaluation of records
management functions IHS-wide; (18)
maintains and updates various
regulatory agendas; (19) manages,
administers, implements and monitors
the IRS’s Paperwork Reduction Act and
Office of Management and Budget
(OMB) information collection/activities;
(20) provides guidance and technical
assistance to JETS regarding information
collection requirements and procedures
for obtaining OMB approvals and
extensions for IHS information
collections; (21) coordinates the
implementation and the application of
Privacy Act, HIPAA Privacy, and
HITECH Act requirements, including
but not limited to HIPAA and HITECH
Act compliance; (22) maintains and
distributes the Compendium of Legal
Opinions; (23) reviews IHS directives
and other issuances for needed legal
clearances; (24) advises on the impact
on IHS and the Indian community of
State and Federal health reforms; and
(25) provides policy review and advice
on the need for or application of legal
opinions.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Section GA–40, Indian Health Service—
Delegations of Authority
[FR Doc. 2014–26203 Filed 11–4–14; 8:45 am]
All delegations of authority and redelegations of authority made to IHS
officials that were in effect immediately
prior to this reorganization, and that are
consistent with this reorganization,
shall continue in effect pending further
re-delegation.
This reorganization shall be effective
on 11/01/2014.
Dated: October 24, 2014.
Yvette Roubideaux,
Acting Director, Indian Health Service.
[FR Doc. 2014–26221 Filed 11–4–14; 8:45 am]
BILLING CODE 4165–16–M
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel; P50 Botanical
Centers.
Date: December 17–18, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Martina Schmidt, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Complementary
& Alternative Medicine, NIH, 6707
Democracy Blvd., Suite 401, Bethesda, MD
20892, 301–594–3456.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: October 30, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
E:\FR\FM\05NON1.SGM
05NON1
Federal Register / Vol. 79, No. 214 / Wednesday, November 5, 2014 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Radiation Therapy and Biology.
Date: November 20, 2014.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact person: Bo Hong, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6194, MSC 7804, Bethesda, MD
20892, 301–996–6208, hongb@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel—Vascular
and Hematology.
Date: November 20, 2014.
Time: 4:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact person: Luis Espinoza, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140,
MSC 7814, Bethesda, MD 20892, 301–435–
0952, espinozala@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: AIDS and Related
Research Integrated Review Group, AIDS
Immunology and Pathogenesis Study
Section.
Date: November 21, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street NW., Washington, DC 20037.
Contact person: Shiv A. Prasad, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220,
MSC 7852, Bethesda, MD 20892, 301–443–
5779, prasads@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
VerDate Sep<11>2014
17:42 Nov 04, 2014
Jkt 235001
Dated: October 29, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–26209 Filed 11–4–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Low-Dose CT
Imaging (U01) (2015/05).
Date: February 6, 2015.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, Suite 920, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: John K. Hayes, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
6707 Democracy Boulevard, Suite 959,
Bethesda, MD 20892, 301–451–3398, hayesj@
mail.nih.gov.
Dated: October 29, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–26207 Filed 11–4–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
65677
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Social Science and Population
Studies.
Date: November 10, 2014.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Valerie Durrant, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148,
MSC 7770, Bethesda, MD 20892, (301) 827–
6390, durrantv@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Radiation Therapy and Biology.
Date: November 13–14, 2014.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Bo Hong, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6194, MSC 7804, Bethesda, MD
20892, 301–996–6208, hongb@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Drug Discovery and Mechanisms of
Antimicrobial Resistance.
Date: November 14, 2014.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street
NW., Washington, DC 20036.
Contact Person: John C. Pugh, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
MSC 7808, Bethesda, MD 20892, (301) 435–
2398, pughjohn@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
E:\FR\FM\05NON1.SGM
05NON1
]]>Agencies
[Federal Register Volume 79, Number 214 (Wednesday, November 5, 2014)]
[Notices]
[Pages 65676-65677]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-26209]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C.,
[[Page 65677]]
as amended. The grant applications and the discussions could disclose
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the grant applications, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Member Conflict: Radiation Therapy and Biology.
Date: November 20, 2014.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact person: Bo Hong, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD 20892, 301-996-
6208, hongb@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel--Vascular and Hematology.
Date: November 20, 2014.
Time: 4:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact person: Luis Espinoza, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD 20892, 301-435-
0952, espinozala@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: AIDS and Related Research Integrated Review
Group, AIDS Immunology and Pathogenesis Study Section.
Date: November 21, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Fairmont Washington, DC, 2401 M Street NW.,
Washington, DC 20037.
Contact person: Shiv A. Prasad, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD
20892, 301-443-5779, prasads@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 29, 2014.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-26209 Filed 11-4-14; 8:45 am]
BILLING CODE 4140-01-P
